Stallion India Fluorochemicals Limited
Lot Size
1 Lot = 165 Qty |
Min Investment
₹14850 |
Subscription
Oversubscribed |
Listing Gain
0(Points) |
IPO Details
Open Date
Jan 16, 2025 |
Close Date
Jan 20, 2025 |
Allotment Date
Jan 21, 2025 |
Allotment Date
Jan 21, 2025 |
Refund Initiation
Jan 22, 2025 |
Demat Transfer
Jan 22, 2025 |
Listing Date
Jan 23, 2025 |
Fresh Issue
160.73 |
Offer For Sale
38.72 |
Issue Price
₹85 to ₹90 |
Face Value
₹10 |
Issue Type
Fresh Issue |
Total Issue Size
199.45 CR |
QIB + NII Quota
50 + 15% |
Retail Quota
35% |
Listing On
NSE & BSE |
Registrar
Bigshare Services Pvt Ltd |
Company Financial Rusult In Crore
PERIOD | ASSET | REVENUE | PROFIT |
---|---|---|---|
30-Sep-2025 | 235.69 | 141.53 | 16.57 |
31-Mar-2024 | 203.14 | 236.23 | 14.79 |
31-Mar-2023 | 126.18 | 226.06 | 9.75 |
31-Mar-2022 | 98.01 | 186.34 | 21.11 |
Concerning The Business
Founded in 2002, Stallion India Fluorochemicals Limited has been engaged in the selling of industrial gases, refrigerants, and their derivatives. The majority of its business consists of debukelling, blending, and processing industrial gases and refrigerants, as well as selling pre-filled cans and tiny cylinders and containers.
It has four plants at Khalapur, Raigad, India; Ghiloth, Alwar, Rajasthan; Manesar, Gurugram, Haryana; and Panvel, Raigad, India.
The gases sold by Stallion India Fluorochemicals Limited (Stallion) are generally classified as fluorochemicals. The main use of these chemicals is in refrigeration. Many facets of society employ Stallions products, including gases, including the creation of semiconductors, cars, electronics, pharmacies, healthcare facilities, fire extinguishers, foam spray, glass bottles, and aerosols.
Stallion India Fluorochemical: Advantages and Disadvantages
Advantages
- Having been in business for more than 20 years, the company is well-known in the specialty gases sector.
- The companys ongoing focus is on its strategic vision to add new goods that complement its current offers in order to diversify its current product line.
Disadvantages
- There are ongoing legal procedures involving the companys directors and promoters. Failure to successfully defend these proceedings could harm company reputation, continued operations, financial situation, and business prospects.
- The companys needs for working capital are substantial. Our companys operations, financial situation, and business could all suffer significantly if it is unable to meet its working capital needs.